Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Desert Labs is an Israeli biotechnology company specializing in the cultivation and processing of Hoodia gordonii for the global health and wellness market. Based in Kibbutz Yotvata, the company utilizes advanced agricultural and stabilization technologies to preserve the plant's active appetite-suppressant compounds, notably the P57 steroid glycoside. Desert Labs manages the entire production process from desert-based cultivation to the manufacturing of functional food ingredients and finished supplements. Their products are designed to support weight management and metabolic health through natural, plant-derived mechanisms. The company is recognized for its ability to grow and stabilize Hoodia at a commercial scale in a controlled desert environment, overcoming the biological challenges of the species.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Desert Labs.